Surgical Decompression for Diabetic Neuropathy in the Foot

Sponsor
Timothy J. Best Medicine Professional Corporation (Other)
Overall Status
Completed
CT.gov ID
NCT01006915
Collaborator
The Physicians' Services Incorporated Foundation (Other)
21
1
2
72
0.3

Study Details

Study Description

Brief Summary

The purpose of the study is to determine whether or not surgical decompression of the common peroneal, tibial, and deep peroneal nerves in the legs of persons with diabetic peripheral neuropathy is effective treatment.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Surgery
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
21 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Surgical Peripheral Nerve Decompression for the Treatment of Diabetic Neuropathy in the Foot
Study Start Date :
Mar 1, 2010
Actual Primary Completion Date :
Mar 1, 2015
Actual Study Completion Date :
Mar 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Surgical decompression

Surgical decompression of the common peroneal, tibial, and deep peroneal nerves

Procedure: Surgery
Surgical decompression of the common peroneal, tibial, and deep peroneal nerves

No Intervention: Standard medical care

Standard diabetic care and medical care provided for diabetic sensorimotor polyneuropathy

Outcome Measures

Primary Outcome Measures

  1. To determine if lower extremity nerve decompression in patients suffering from symptomatic diabetic peripheral neuropathy significantly alleviates pain. [0,3,6, and 12 months]

Secondary Outcome Measures

  1. Neuropathic Symptoms as measured by the Total Neuropathy Score (TNS) [0,3,6, and 12 months]

  2. Signs of peripheral neuropathy - two-point discriminations and pressure thresholds, vibration sensibility [0 and 12 months]

  3. Nerve Conduction Velocity [0 and 12 months]

  4. Quality of Life [0,3,6, and 12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age >18 years

  • Presence of Type 1 or 2 diabetes mellitus (fasting plasma glucose > 7 mmol/L or casual plasma glucose > 11.1 mmol/L and symptoms of diabetes or a 2hr plasma glucose in a 75g oral glucose tolerance test > 11.1 mmol/L)

  • Symptoms of paresthesias (including burning pain) or numbness present symmetrically in both feet, determined to be on a peripheral nerve basis

  • Total Neuropathy score of ≥ 2 based on symptoms, signs, and nerve conduction study abnormality

  • Average pain on Likert scale (range 0 - 10) ≥5

  • Good diabetic control with Hgb A1C < 8

  • Presence of Tinel's sign at the Tarsal Tunnel

  • Possession of valid Ontario Hospital Insurance Plan (OHIP) coverage

Exclusion Criteria:
  • Other types of diabetes mellitus (gestational, drug-induced, etc.)

  • Other cause of neuropathy than diabetes such as vasculitis, amyloidosis, toxic neuropathy, HIV, renal failure, alcohol abuse, etc. Pure entrapment neuropathy without evidence of DSP

  • Symptomatic lumbosacral spine disease

  • Symptomatic lower extremity vascular disease

  • Previous foot ulceration or amputation. Other contraindications to surgery such as significant ankle edema, venous stasis, morbid obesity, or previous surgery/injury which would be incompatible with appropriate wound healing

  • History of Peripheral Arterial Disease

  • HbA1c > 8.0 - Adults lacking capacity to consent, pregnant women, prisoners, non-English speakers who require an interpreter, and those unwilling or unable to participate in the full study follow-up

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sault Area Hospital Sault Ste. Marie Ontario Canada P6A 2C4

Sponsors and Collaborators

  • Timothy J. Best Medicine Professional Corporation
  • The Physicians' Services Incorporated Foundation

Investigators

  • Principal Investigator: Timothy J Best, MD, MSc, Northern Ontario School of Medicine
  • Study Director: Sante Fratesi, MD, MSc, Northern Ontario School of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Timothy J. Best Medicine Professional Corporation
ClinicalTrials.gov Identifier:
NCT01006915
Other Study ID Numbers:
  • DPNPSI-1
First Posted:
Nov 3, 2009
Last Update Posted:
May 5, 2016
Last Verified:
May 1, 2016
Keywords provided by Timothy J. Best Medicine Professional Corporation
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 5, 2016